Search research articles
Contact Us
Filters
Showing results (181-190 of 188) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 188 results.
Journal of Translational Medicine
|
February 24, 2020
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
Sinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, et al.
Therapeutic Advances in Medical Oncology
|
June 5, 2023
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy
Dennis J Slamon, Peter A Fasching, Sara Hurvitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2021
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors
Seodhna M Lynch, Niamh M Russell, Stephen Barron, et al.
The New England Journal of Medicine
|
March 20, 2024
Ribociclib plus Endocrine Therapy in Early Breast Cancer
Dennis Slamon, Oleg Lipatov, Zbigniew Nowecki, et al.
Therapeutic Advances in Medical Oncology
|
August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial
Giuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2024
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma
Omid Hamid, Karl D Lewis, Amy Weise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 18, 2020
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
Cristina Saura, Mafalda Oliveira, Yin-Hsun Feng, et al.
Breast Cancer Research and Treatment
|
June 14, 2021
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study
Lisa Prior, Richard O'Dwyer, Abdul Rehman Farooq, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 188) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 188 results.
Journal of Translational Medicine
|
February 24, 2020
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
Sinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, et al.
Therapeutic Advances in Medical Oncology
|
June 5, 2023
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy
Dennis J Slamon, Peter A Fasching, Sara Hurvitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2021
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors
Seodhna M Lynch, Niamh M Russell, Stephen Barron, et al.
The New England Journal of Medicine
|
March 20, 2024
Ribociclib plus Endocrine Therapy in Early Breast Cancer
Dennis Slamon, Oleg Lipatov, Zbigniew Nowecki, et al.
Therapeutic Advances in Medical Oncology
|
August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial
Giuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2024
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma
Omid Hamid, Karl D Lewis, Amy Weise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 18, 2020
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
Cristina Saura, Mafalda Oliveira, Yin-Hsun Feng, et al.
Breast Cancer Research and Treatment
|
June 14, 2021
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study
Lisa Prior, Richard O'Dwyer, Abdul Rehman Farooq, et al.
Page
of 19